ArticleBMC musculoskeletal disorders2025
An MRI-based radiomics framework for early identification and progression stratification in knee osteoarthritis: data from the osteoarthritis initiative.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Oridonin ameliorates the ferroptosis of chondrocyte to play a chondroprotective role in osteoarthritis.Journal of bioenergetics and biomembranes · 2026Article
- Review
- Objective stratification of knee osteoarthritis stages using a semi-supervised learning approach on multimodal MRI-CT cartilage features.Frontiers in digital health · 2026Article
- Artificial intelligence and big data for precision regenerative medicine in knee osteoarthritis: endotyping, responder prediction, and clinical translation.Frontiers in bioengineering and biotechnology · 2026Review
- Structured MOAKS-based MRI features for predicting medial joint space narrowing progression: a comparative osteoarthritis initiative study.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesTo develop a cascaded machine learning model based on MRI radiomics features from cartilage and subchondral bone to predict the incidence and progression of knee osteoarthritis (KOA), thereby addressing the need for early intervention in pre-radiographic stages. MATERIALS AND
methodsThe study analyzed 456 participants without radiographic OA (Kellgren-Lawrence [KL] 0-1) at baseline were selected from the Osteoarthritis Initiative (OAI) and randomly divided into training and testing cohorts (7:3). Participants underwent 3D DESS MRI of the right knee and were stratified into incident KOA and non-KOA groups based on 4-year radiographic outcomes, using 1:2 propensity score matching (PSM) to adjust for baseline confounders. Early and late progressors were further classified based on the timing of radiographic progression. Radiomic features of cartilage and subchondral bone were extracted from nnU-Net-based segmentation. Optimal features were selected through Least Absolute Shrinkage and Selection Operator (LASSO) regression and principal component analysis (PCA). A two-stage logistic regression (LR) classification framework was developed to predict KOA incidence and progression, with a cascaded LR model implemented for multi-class classification. Model performance was primarily evaluated using the area under curve (AUC), with SHapley Additive exPlanations (SHAP) for interpretability.
resultsSHAP analysis identified square_glrlm_ShortRunLowGrayLevelEmphasis and wavelet-HHL_firstorder_Minimum from subchondral bone as primary predictors. The combined cartilage and subchondral bone radiomics models demonstrated superior performance in predicting incidence (AUC: 0.985, 95% CI: 0.969-1.000) and progression (AUC: 0.738, 95% CI: 0.565-0.911) of KOA. The cascaded model achieved AUCs > 0.800 across categories, with an overall accuracy of 0.791.
conclusionsThe MRI radiomics framework integrating cartilage and subchondral bone features, effectively predicts KOA incidence and progression, enhances individualized risk stratification, and facilitates timely clinical decisions.
trial registrationClinical trial number not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.